Utility of F-18 Fluorothymidine PET Over F-18 Fluorodeoxyglucose PET/CT in Detection of a Recurrent Glioma
Raghava Kashyap, Manoj Kumar Tiwari, Raja Senthil, Anish Bhattacharya, Vivek Gupta, Bhagwant Rai Mittal
Citation Information :
Kashyap R, Tiwari MK, Senthil R, Bhattacharya A, Gupta V, Mittal BR. Utility of F-18 Fluorothymidine PET Over F-18 Fluorodeoxyglucose PET/CT in Detection of a Recurrent Glioma. J Postgrad Med Edu Res 2012; 46 (4):202-203.
Kashyap R, Tiwari MK, Senthil R, Bhattacharya A, Gupta V, Mittal BR. Utility of F-18 Fluorothymidine PET Over F-18 Fluorodeoxyglucose PET/CT in Detection of a Recurrent Glioma. J Postgrad Med Edu Res 2012;46(4):202-203.
F-18 FDG PET/CT in patients with recurrent glioma: Comparison with contrast enhanced MRI. Eur J Radiol 2011 Feb 23.
Single-photon emission computed tomography: Computed Tomography in brain tumors. Semin Nucl Med 2007;37:34-47.
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas. Clin Nucl Med 2009;34:878-83.
Imaging proliferation in brain tumors with 18F-FLT PET: Comparison with 18F-FDG. J Nucl Med 2005;46:945-52.
11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Eur J Nucl Med Mol Imaging 2008;35:2009-17.
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3′-deoxy-3′-[18F] fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: Preliminary efficacy studies. Mol Imaging Biol 2009;11:343-55.
Imaging regional variation of cellular proliferation in gliomas using 3′-deoxy-3′-[18F] fluorothymidine positronemission tomography: An image-guided biopsy study. Clin Radiol 2009;64:52-63.
Evaluation of primary brain tumors with FLT-PET: Usefulness and limitations. Clin Nucl Med 2006;31: 774-80.
3′-deoxy-3′-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: Comparison with Gd-DTPA enhanced magnetic resonance imaging. Mol Imaging Biol 2006;8:340-47.
